The potential of curcumin in mitigating acetaminophen-induced liver damage
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-07 · 398 (7) · 8169-8188
DOI: 10.1007/s00210-025-03907-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 26.02.2025. Verfasst von Elham Einafshar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Curcumin, Acetaminophen, Chemical and Drug Induced Liver Injury, Analgesics, Non-Narcotic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 164 Literaturangaben.
Abstract (Originalsprache)
Acetaminophen (APAP) is a widely used over-the-counter medication for pain and fever, but its overuse can lead to liver toxicity, hepatocyte apoptosis, and necrosis. Despite therapeutic advances in drug-induced hepatotoxicity, APAP-induced liver damage still poses a medical challenge. Recently, natural products have emerged as potential options for mitigating the effects of APAP hepatotoxicity. Curcumin, a natural compound with antioxidant and anti-inflammatory properties, has shown promising results in drug-induced hepatotoxicity. However, further investigations are needed to assess the clinical benefits of curcumin. In this review, we discuss the mechanisms of APAP-induced liver damage and the role of curcumin in preventing liver necrosis, oxidative stress, inflammation, and apoptosis caused by APAP overdose. Through its ability to scavenge free radicals, prevent lipid peroxidation, restore glutathione (GSH) levels, and inhibit apoptosis, curcumin has been found to significantly reduce oxidative stress and protect liver tissue from APAP toxicity in various studies. This paper also reviews the potential of novel nanoformulations to enhance the bioavailability of curcumin for improved therapeutic outcomes. Overall, the evidence suggests that curcumin could be a promising intervention to mitigate the harmful effects of APAP overdose and improve liver health. However, further research is required to assess the optimal dosing and timing of curcumin administration in APAP toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran.
- School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
- School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. SahebkarA@mums.ac.ir.
- Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. SahebkarA@mums.ac.ir.
- Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. HoseiniHS@mums.ac.ir.
Zitieren
APA
Einafshar, E., Bahrami, P., Pashaei, F., Naseri, P., Ay Gharanjik, A., Mirteimoori, A., Daraeebaf, N., Marami, Y., Sahebkar, A., & Hosseini, H. (2025). The potential of curcumin in mitigating acetaminophen-induced liver damage. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(7), 8169-8188. https://doi.org/10.1007/s00210-025-03907-4
Vancouver
Einafshar E, Bahrami P, Pashaei F, Naseri P, Ay Gharanjik A, Mirteimoori A, et al. The potential of curcumin in mitigating acetaminophen-induced liver damage. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(7):8169-8188. doi:10.1007/s00210-025-03907-4
BibTeX
@article{Einafshar2025,
author = {Einafshar, Elham and Bahrami, Pegah and Pashaei, Fatemeh and Naseri, Paniz and Ay Gharanjik, Altin and Mirteimoori, Atefe and Daraeebaf, Nastaran and Marami, Yegane and Sahebkar, Amirhossein and Hosseini, Hossein},
title = {The potential of curcumin in mitigating acetaminophen-induced liver damage},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
volume = {398},
number = {7},
pages = {8169--8188},
doi = {10.1007/s00210-025-03907-4}
}
EUVIMED